Bariatric surgery following treatment for craniopharyngioma: A systematic review and individual-level data meta-analysis

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 6, 2013, Pages 2239-2246

  Bretault, Marion ^a   Boillot, Adrien ^c,d   Muzard, Ludivine ^a,b   Poitou, Christine ^e,f,g   Oppert, Jean Michel ^e,f   Barsamian, Charles ^a   Gatta, Blandine ^h,n   Mul̈ler, Herman ⁱ   Weismann, Dirk ^j   Rottembourg, Diane ^k   Inge, Thomas ^l   Veyrie, Nicolas ^a,b   Carette, Claire ^a   Czernichow, Seb́astien ^a,b,m  

^a HÔPITAL AMBROISE PARÉ   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^c HÔPITAL ROTHSCHILD   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f SORBONNE UNIVERSITÉ   (France)

^g INSERM   (France)

^h HAUT LÉVÊQUE HOSPITAL   (France)

ⁱ EMAU Greifswald   (Germany)

^j UNIVERSITY OF WÜRZBURG   (Germany)

^k CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^l CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^m CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

ⁿ UNIVERSITÉ DE BORDEAUX   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY MASS; CRANIOPHARYNGIOMA; DIABETES MELLITUS; FOLLOW UP; GASTRIC BANDING; HEALTH STATUS; HUMAN; HYPERTENSION; HYPOTHALAMIC OBESITY; META ANALYSIS; NEUROSURGERY; OBESITY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; STOMACH BYPASS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WEIGHT REDUCTION; ADOLESCENT; ADULT; CHILD; FEMALE; HYPOPHYSIS TUMOR; HYPOTHALAMUS DISEASE; MALE; PRESCHOOL CHILD;

ADOLESCENT; ADULT; BARIATRIC SURGERY; CHILD; CHILD, PRESCHOOL; CRANIOPHARYNGIOMA; FEMALE; HUMANS; HYPOTHALAMIC DISEASES; MALE; OBESITY; PITUITARY NEOPLASMS; WEIGHT LOSS;

MLCS; MLOWN;

EID: 84878501554     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-4184     Document Type: Review

References (56)

1. Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J Neurosurg. 1998;89:547-551. (Pubitemid 28440922)
2. Hermann L, Müller HL. Consequences of craniopharyngioma surgery in children. J Clin Endocrinol Metab. 2011;96:1981-1991.
3. Müller HL, Bueb K, Bartels U, et al. Obesity after craniopharyngioma: German multicenter study on pre-operative risk factors and quality of life. Klin Padiatr. 2001;213:244-249. (Pubitemid 32801576)
4. Ahmet A, Blaser S, Stephens D, Guger S, Rutkas JT, Hamilton J. Weight gain in craniopharyngioma: a model for hypothalamic obesity. J Pediatr Endocrinol Metab. 2006;19:121-127. (Pubitemid 43337887)
5. Müller HL, Emser A, Faldum A, et al. Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab. 2004;89:3298-3305. (Pubitemid 38951896)
6. Lustig RH, Post SR, Srivannaboon K, et al. Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab. 2003;88:611-616. (Pubitemid 36207799)
7. Gautier A, Godbout A, Grosheny C, et al. Markers of recurrence and long-term morbidity in craniopharyngioma: a systematic analysis of 171 patients. J Clin Endocrinol Metab. 2012;97:2011-2817.
8. Lustig RH. Hypothalamic obesity after Craniopharyngioma: mechanisms, diagnosis, and treatment. Front Endocrinol (Lausanne). 2011;2:60.
9. Molloy PT, Berkowitz R, Stallings VA, et al. Pilot study of evaluation and treatment of tumour-related obesity in pediatric patients with hypothalamic/chiasmatic gliomas and craniopharyngiomas. In: Proceedings of the International Pediatric Oncology Meeting, October 4-7, 1998; Rome, Italy. Abstract 156.
10. Danielsson P, Janson A, Norgren S, Marcus C. Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes. J Clin Endocrinol Metab. 2007;92:4101-4106. (Pubitemid 350074718)
11. Mason PW, Kraviecki N, Meacham LR. The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch Pediatr Adolesc Med. 2002;156:887-892. (Pubitemid 36343499)
12. Page-Wilson G, Wardlaw SL, Khandji AG, Korner J. Hypothalamic obesity in patients with craniopharyngioma: treatment approaches and the emerging role of gastric bypass surgery. Pituitary. 2012;15:84-92.
13. Lustig RH, Rose SR, Burghen GA, et al. Hypothalamic obesity in children caused by cranial insult: altered glucose and insulin dynamics, and reversal by a somatostatin agonist. J Pediatr. 1999;135:162-168. (Pubitemid 30180530)
14. Hamilton JK, Conwell LS, Syme C, Ahmet A, Jeffery A, Daneman D. Hypothalamic obesity following craniopharyngioma surgery: results of a pilot trial of combined diazoxide and metformin therapy. Int J Pediatr Endocrinol. 2011;2011:417949.
15. Sjöström L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-2693. (Pubitemid 39665322)
16. Lemmens VE, Oenema A, Klepp KL, Henriksen HB, Brug J. A systematic review of the evidence regarding efficacy of obesity prevention interventions among adults. Obes Rev. 2008;9:446-455.
17. Lara M, Amigo H. What kind of intervention has the best results to reduce the weight in overweighted or obese adults? Arch Latinoam Nutr. 2011;61:45-54.
18. Colquitt JL, Picot J, Loveman E, Clegg AJ. Surgery for obesity. Cochrane Database Syst Rev. 2009;(2):CD003641. doi:10.1002/14651858.CD003641.pub3.
19. Padwal R, Klarenbach S, Wiebe N, et al. Bariatric surgery: a systematic review and network meta-analysis of randomized trials. Obes Rev. 2011;12:602-621.
20. Bingham NC, Rose SR, Inge TH. Bariatric surgery in hypothalamic obesity. Front Endocrinol (Lausanne). 2012;3:23.
21. Stroup DF, Berlin JA, Morton SC. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-2012. (Pubitemid 30214957)
22. Hedges LV, Oklin I. Statistical methods for meta-analysis. Orlando, FL: Academic Press; 1985.
23. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560. (Pubitemid 37088507)
24. Weismann D, Pelka T, Bender G, et al. Bariatric surgery for morbid obesity in craniopharyngioma. Clin Endocrinol (Oxf). 2013;78:385-390
25. Rottembourg D, O'Gorman CS, Urbach S, et al. Outcome after bariatric surgery in two adolescents with hypothalamic obesity following treatment of craniopharyngioma. J Pediatr Endocrinol Metab. 2009;22:867-872.
26. Müller HL, Gebhardt U, Wessel V, et al. First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity. Klin Pädiatr. 2007;219:323-325. (Pubitemid 350239733)
27. Inge T, Pfluger P, Zeller M, et al. Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy. Nat Clin Pract Endocrinol Metab. 2007;3:606-609. (Pubitemid 47094564)
28. Gatta B, Nunes ML, Bailacq-Auder C, Etchechoury L, Collet D, Tabarin A. Is bariatric surgery really inefficient in hypothalamic obesity? Clin Endocrinol (Oxf). 2013;78:636-638.
29. Bender G, Fassnacht M, Jurowich C, Renner T, Thalheimer A, Allolio B. Beneficial results of sleeve gastrectomy in a 12-year old girl with massive hyperphagia after surgery for craniopharyngioma. Obes Surg. 2011;21:956-1156.
30. Schultes B, Ernst B, Schmid F, Thurnheer M. Distal gastric bypass surgery for the treatment of hypothalamic obesity after childhood craniopharyngioma. Eur J Endocrinol. 2009;161:201-206.
31. Sarson DL, Scopirano N, Bloom SR. Gut hormone changes after jejunoileal or biliopancreatic bypass surgery for morbid obesity. Int J Obes. 1981;5:471-480. (Pubitemid 11014634)
32. Laferre B, Teixera J, Mcginty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab. 2008;93:2479-2485.
33. Vinchon M, Weill J, Delestret I, Dhellemmes P. Craniopharyngioma and hypothalamic obesity in children. Childs Nerv Syst. 2009;25:347-352.
34. Hou Z, Miao Y, Gao L, Pan H, Zhu S. Ghrelin-containing neuron in cerebral cortex and hypothalamus linked with the DVC of brainstem in rat. Regul Pept. 2006;134:126-131.
35. Abizaid A, Liu ZW, Andrews ZB, et al. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest. 2006;116:3229-3239. (Pubitemid 44878637)
36. De Silva A, Salem V, Matthews PM, Dhillo WS. The use of functional MRI to study appetite control in the CNS. Exp Diabetes Res. 2012;2012:764017.
37. De Silva A, Salem V, Long CJ, et al. The gut hormones PYY3-36 and GLP-17-36 amide reduce food intake and modulate brain activity in appetite centers in humans. Cell Metab. 2011;14:700-706.
38. Kral JG. Vagotomy for treatment of severe obesity. Lancet. 1978;1:307-308. (Pubitemid 8273565)
39. Angrisani L, Cutolo PP, Ciciriello MB, et al. Laparoscopic adjustable gastric banding with truncal vagotomy versus laparoscopic adjustable gastric banding alone: results of a prospective randomized trial. Surg Obes Relat Dis. 2009;5:435-438.
40. Wiegele K, Prager G, Benesch M et al. Impressive weight reduction following laparoscopic gastric bypass surgery in a 16-year old girl with suprasellar craniopharyngioma and extreme hypothalamic obesity. Neuro Oncol. 2010;12:II122.
41. Boza C, Salinas J, Salgado N, et al. Laparoscopic sleeve gastrectomy as a stand-alone procedure for morbid obesity: report of 1,000 cases and 3-year follow-up. Obes Surg. 2012;22:866-871.
42. Holterman AX, Holterman M, Browne A, Henriques S, Guzman G, Fantuzzi G. Patterns of surgical weight loss and resolution of metabolic abnormalities in superobese bariatric adolescents. J Pediatr Surg. 2012;47:1633-1639.
43. Nadler EP, Youn HA, Ginsburg HB, Ren CJ, Fielding GA. Short-term results in 53 obese pediatric patients treated with laparoscopic adjustable gastric banding. J Pediatr Sur. 2007;42:137-142. (Pubitemid 46037725)
44. Nadler EP, Barefoot LC, Qureshi FG. Early results after laparoscopic sleeve gastrectomy in adolescents with morbid obesity. Surgery. 2012;152:212-217.
45. O'Brien PE, Sawyer SM, Laurie C, et al. Laparoscopic adjustable gastric banding in severely obese adolescents: a randomized trial. JAMA. 2010;303:519-526.
46. Pallati P, Buettner S, Simorov A, Meyer A, Shaligram A, Oleynikov D. Trends in adolescent bariatric surgery evaluated by UHC database collection. Surg Endosc. 2012;26:3077-3081.
47. Mechanick JI, Kushner RF, Sugerman HJ, et al. American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic and Bariatric Surgery: medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity (Silver Spring). 2009;17(suppl 1):S1-S70.
48. Consensus Development Conference Panel. NIH conference: gastrointestinal surgery for severe obesity. Ann Intern Med. 1991;115:956-961.
49. Ibele AR, Mattar SG. Adolescent bariatric surgery. Surg Clin North Am. 2011;91:1339-1351.
50. Hsia DS, Fallon SC, Brandt ML. Adolescent bariatric surgery. Arch Pediatr Adolesc Med. 2012;166(8):757-766.
51. August GP, Caprio S, Fennoy I, et al. Prevention and treatment of pediatric obesity: an Endocrine Society Clinical Practice Guideline based on expert opinion. J Clin Endocrinol Metab. 2008;93:4576-4599.
52. IPEG Standard and Safety Committee. IPEG guidelines for surgical treatment of extremely obese adolescents. J Laparoendosc Adv Surg Tech A. 2009;19:xiv-xvi.
53. Inge TH, Jenkins TM, Zeller M, et al. Baseline BMI is a strong predictor of nadir BMI after adolescent gastric bypass. J Pediatr. 2010;156:103-108.
54. Padwal R, Brocks D, Sharma AM. A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev. 2010;11:41-50.
55. Day S. Evidence-based medicine and rare diseases. Adv Exp Med Biol. 2010;686:41-53.
56. Carey JC. The importance of case reports in advancing scientific knowledge of rare diseases. Adv Exp Med Biol. 2010;686:77-86.